Aspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics

Published: 01/08/2025

Aspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics

tags

Latest News

NEWS 03.03.2026

American Medical Wellness and American Wellness Pharmacy Highlight Rare, Vertically Integrated Model Bringing Physician-Led Care and 503A Compounding Under One Roof in Las Vegas – FinancialContent

NEWS 03.03.2026

MUSC Researcher Leads $1 Million Effort to Transform Type 1 Diabetes Treatment – SSBCrack News

NEWS 03.03.2026

Mesoblast ASX 100 Index Outlook After Earnings Update – Kalkine Media

NEWS 03.03.2026

CollPlant targets formulation bottleneck with new DLP bioprinting kit – 3D Printing Industry